Synthetic cannabis compounds used to tackle diabetes linked kidney failure

Warning message

The subscription service is currently unavailable. Please try again later.

New substances derived from cannabis are being used to tackle kidney failure linked to diabetes as part of a new research project.

Around 40% of people who have diabetes go on to develop kidney failure, also known as diabetic nephropathy.

The project, being led by the University of Aberdeen, is looking at whether synthetic cannabinoid compounds can help the kidneys respond better to insulin, the hormone everyone with type 1 diabetes needs to take to control their blood glucose levels.

Loading article content

More than three million people in the UK currently have diabetes and by 2025 the number is expected to rise to five million. By 2040 there will be 640 million across the world living with the condition, scientists estimate.

Researchers said active ingredients in the cannabis plant are already known to have beneficial effects for the treatment of a number of conditions, including rheumatoid arthritis.

They do...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.